0.01%阿托品滴眼液联合Flipper镜对中度近视患儿视力恢复的影响

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1187 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要目的探讨0.01%阿托品滴眼液联合Flipper镜对中度近视患儿视力恢复的影响。方法选取2020年1月—2021年12月本院收治的中度近视患儿76例(140眼)的临床资料,使用随机数字表法分为对照组(72眼)、观察组(68眼),每组38例。对照组患儿接受0.01%阿托品滴眼液,观察组患儿接受0.01%阿托品滴眼液联合Flipper镜治疗。测定2组患儿治疗前、治疗6个月的屈光度、裸眼视力、眼轴长度、瞳孔直径、眼压及调节灵敏度,并对比2组眼部不适症状发生率。结果 2组治疗6个月的屈光度均较治疗前降低,裸眼视力、瞳孔直径、调节灵敏度较治疗前升高,且观察组的屈光度为(-2.20±0.64)D,对照组为(-2.83±0.70)D,观察组裸眼视力(0.75±0.10)、瞳孔直径(6.59±1.01)mm、调节灵敏度(18.42±3.11)cpm,对照组分别为(0.63±0.14)、(5.04±0.88)mm、(14.28±2.82)cpm,差异有统计学意义(t=4.095、4.299、7.133、4.611,P均<0.001)。2组治疗前眼压水平(18.18±2.15)mmHg vs (18.20±2.12)mmHg、治疗6个月眼压水平(18.50±2.13)mmHg vs (18.40±2.20)mmHg,差异均无统计学意义(t=0.041、0.201,P=0.968、0.841)。对照组不适症状发生率为6.94%,观察组为5.88%,2组差异无统计学意义(χ2=0.008,P=0.929)。结论 0.01%阿托品滴眼液联合Flipper镜可有效促进中度近视患儿的视力恢复,且具有较高的安全性,值得推广。　

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	曹晓青
	张旭

关键词 ：近视, 儿童, 阿托品滴眼液, Flipper镜, 屈光度, 调节灵敏度

Abstract：Objective To investigate the effect of 0.01% atropine eye drops combined with Flipper lens on visual recovery in children with moderate myopia. Methods The clinical data of 76 children with moderate myopia (140 eyes) admitted to our hospital from January 2020 to December 2021 were selected, and they were divided into a control group (72 eyes) and an observation group (68 eyes) by random number table method, with 38 cases in each group. The children in the control group received 0.01% atropine eye drops, and the children in the observation group received 0.01% atropine eye drops combined with Flipper lens. The diopter, unaided visual acuity, axial length, pupil diameter, intraocular pressure, and accommodative sensitivity were measured before treatment and 6 months after treatment in the two groups, and the incidence of ocular discomfort symptoms was compared between the two groups. Results The diopters of the two groups after 6 months of treatment were lower than those before treatment, and the naked eye visions, pupil diameters, and adjustment sensitivities were higher than those before treatment. The diopter of the observation group was (-2.20±0.64) D, lower than that of the control group: (-2.83±0.70) D. The naked eye vision, pupil diameter, and adjustment sensitivity of the observation group were (0.75±0.10), (6.59±1.01) mm, and (18.42±3.11) cpm, respectively, higher than those of the control group: (0.63±0.14), (5.04±0.88) mm, and (14.28±2.82) cpm, respectively, and the differences were statistically significant (t=4.095, 4.299, 7.133, 4.611, all P<0.001). There was no statistically significant difference between the two groups in intraocular pressure levels before treatment: (18.18±2.15) mmHg vs (18.20±2.12) mmHg, and after 6 months of treatment: (18.50±2.13) mmHg vs (18.40±2.20) mmHg (t=0.041, 0.201, P=0.968, 0.841). The incidence of uncomfortable symptoms was 6.94% in the control group and 5.88% in the observation group, and there was no significant difference between the two groups (χ2=0.008, P=0.929). Conclusion The 0.01% atropine eye drops combined with Flipper lens can effectively promote the recovery of vision in children with moderate myopia, and it has high safety, which is worth promoting.

Key words： Myopia Child Atropine eye drops Flipper lens Diopter Adjustment sensitivity

收稿日期: 2023-02-15

ZTFLH:

R778.1+1

作者简介: 曹晓青(1989—),女,河南商丘人,主治医师,本科学历,主要从事眼科工作。

引用本文:

曹晓青,张旭. 0.01%阿托品滴眼液联合Flipper镜对中度近视患儿视力恢复的影响[J]. 中国校医, 2024, 38(1): 58-60,64.
CAO Xiaoqing, ZHANG Xu. Effects of 0.01% atropine eye drops combined with Flipper lens on visual recovery in children with moderate myopia. Chinese Journal of School Doctor, 2024, 38(1): 58-60,64.

链接本文:

https://www.zgxyzz.org.cn/CN/ 或 https://www.zgxyzz.org.cn/CN/Y2024/V38/I1/58

[1] 钟盼亮,刘云飞,马宁,等.中国9个省(自治区、直辖市)小学生户外时间对近视发生影响的队列研究[J].中华流行病学杂志,2022,43(7):1099-1106.
[2] 王媛媛,耿鑫,钟佳杰,等.学龄期儿童青少年近视患者生存质量研究[J].中华眼视光学与视觉科学杂志,2022,24(6):447-453.
[3] 代小婵,张静,鞠雅晗,等.近视发生发展中脉络膜变化的研究进展[J].中华眼视光学与视觉科学杂志,2022,24(5):395-400.
[4] 李双莲.低浓度阿托品滴眼液延缓儿童青少年不同程度近视的有效性和安全性研究[D]. 南昌:南昌大学,2020:21-39.
[5] 费璇.视功能训练配合硫酸阿托品滴眼液对青少年初发近视的应用价值[J].临床研究,2021,29(10):72-74.
[6] 甄毅,曹凯,高杰.降低框架眼镜球镜度数间隔有可能延缓青少年近视进展[J].眼科,2022,31(2):89-93.
[7] 褚慧慧,赵寅政,张俊娜,等.儿童近视早期不同干预方法的疗效分析[J].中国斜视与小儿眼科杂志,2022,30(1):5-7,38.
[8] 廖晶,朱琳,陈泽恺.中小学生视疲劳发生及其风险因素的研究[J].中国校医,2022,36(3):164-166,227.
[9] 符爱存,赵兵新,张俊杰,等.近视儿童应用0.01%硫酸阿托品滴眼液的不良反应[J].中华实验眼科杂志,2018,36(6):449-453.
[10] 朱勤,周圆,张晓帆,等.0.05%阿托品滴眼液对小学生近视控制的有效性和安全性[J].中国学校卫生,2021,42(2):170-172,176.
[11] 吕月娥,熊永强,林琳,等.户外活动联合0.01%阿托品滴眼液对学龄期儿童近视发展的影响[J].中国妇幼保健,2021,36(2):335-338.
[12] 刘姗,王海伟,田沫,等.低浓度阿托品不同给药方式治疗青少年近视有效性及安全性的临床研究[J].中国斜视与小儿眼科杂志,2022,30(1):15-18.
[13] 徐浩,白宁艳,姜振芳,等.调节训练对近视儿童屈光度发展的影响作用[J].中国妇幼保健,2015,30(1):65-66.
[14] 刘淑媛,董红丽.Flipper镜视觉调节训练应用于弱视儿童治疗的疗效观察[J].新疆医学,2019,49(6):619-621.
[15] 李丽萍,赵洪超,陈前,等.0.01%阿托品滴眼液联合视功能训练在轻度近视患者中的疗效及对视力水平的影响[J].昆明医科大学学报,2021,42(6):67-71.
[16] Chia A,Lu QS,Donald T,et al. Five-year clinical trial on atropinefor the treatment of myopia 2 myopia control with atropine 0.01%eyedrops[J]. Ophthalmology,2016,123(2):391-399.